Sponsor:
Massachusetts General Hospital
Code:
NCT05998330
Conditions
Liver Disease Chronic
End Stage Liver DIsease
Cirrhosis
Cirrhosis, Liver
Advanced Cirrhosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
LiverPAL
Brief summary:
Conditions
Liver Disease Chronic
End Stage Liver DIsease
Cirrhosis
Cirrhosis, Liver
Advanced Cirrhosis
Study ID
NCT05998330
Start date
Sep 20, 2023
Status verified date
Jul, 2025
Completion date
Jul, 2027
Anticipated
Primary completion date
Jul, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
200 participants
Anticipated
Allocation
Randomized
Intervention Model
Single group
Primary purpose
Supportive Care
Arms
no intervention: Usual Hepatology Care
experimental: Usual Hepatology Care with Early Palliative Care
Interventions
LiverPAL
Primary outcome measure
Central contacts
Locations
Massachusetts General Hospital
Recruiting
Boston, Massachusetts, United States, 02114
Contacts
Principal Investigator:
Nneka N Ufere, MD MSCE
Sponsor
Massachusetts General Hospital
Last update posted
Jul 17, 2025
Last verified
Jul, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2025-07-17.